(Total Views: 3136)
Posted On: 03/02/2017 2:04:31 PM
Post# of 1460
AVXL-Four presentations at uo-coming conferences.
Thursday, March 30; 14:45-16:45: HALL A
AD/PDTM 2017 FORUM ON TRANSLATIONAL RESEARCH IN DRUG DISCOVERY FOR AD: A PLETHORA OF TARGETS: WHICH IS THE BEST, IS THERE "A BEST ONE"?
30-Mar-2017 17:15 19:15
S23 SYMPOSIUM
SYMPOSIUM 23 - SYNAPTIC AND CHOLINERGIC DEFICITS, Ca2+ . ER STRESS, SIGMA-1 RECEPTORS, GPCRS
31-Mar-2017 08:00 18:00
Abstract: 109
15-MONTHS SAFETY AND EXPLORATORY EFFICACY DATA OF ANAVEX 2-73 IN A PHASE 2A STUDY IN MILD-TO-MODERATE ALZHEIMER’S DISEASE PATIENTS
01-Apr-2017 08:00 18:00
Abstract: 007
THE DUAL REGULATION OF OXIDATIVE STRESS BY SIGMA1 RECEPTORS IN PHYSIOLOGICAL OR PATHOLOGICAL CONDITIONS
Thursday, March 30; 14:45-16:45: HALL A
AD/PDTM 2017 FORUM ON TRANSLATIONAL RESEARCH IN DRUG DISCOVERY FOR AD: A PLETHORA OF TARGETS: WHICH IS THE BEST, IS THERE "A BEST ONE"?
30-Mar-2017 17:15 19:15
S23 SYMPOSIUM
SYMPOSIUM 23 - SYNAPTIC AND CHOLINERGIC DEFICITS, Ca2+ . ER STRESS, SIGMA-1 RECEPTORS, GPCRS
31-Mar-2017 08:00 18:00
Abstract: 109
15-MONTHS SAFETY AND EXPLORATORY EFFICACY DATA OF ANAVEX 2-73 IN A PHASE 2A STUDY IN MILD-TO-MODERATE ALZHEIMER’S DISEASE PATIENTS
01-Apr-2017 08:00 18:00
Abstract: 007
THE DUAL REGULATION OF OXIDATIVE STRESS BY SIGMA1 RECEPTORS IN PHYSIOLOGICAL OR PATHOLOGICAL CONDITIONS
(0)
(0)
